Skip to content

HARVARD BIOSCIENCE INC

HBIO

CIK 0001123494

← back to feed
Revenue (TTM)
$83.57M
−8.1% YoY Q1 May 2026
Net Income (TTM)
−$57.28M
−357.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$12.27
−357.1% YoY Q1 May 2026
Gross Margin
57.4%
Q1 May 2026
Operating Margin
-61.6%
Q1 May 2026
Net Margin
-68.5%
Q1 May 2026
Free Cash Flow (TTM)
$3.73M
Q1 May 2026
Cash
$7.1M
Q1 May 2026
Total Debt
$36.21M
Q1 May 2026
Shares Outstanding
4.51M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings